COMMUNIQUÉS West-GlobeNewswire
-
Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
08/04/2026 -
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19
08/04/2026 -
Biora Therapeutics Advances BioJet™ Swallowable Autoinjector
08/04/2026 -
UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
08/04/2026 -
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
08/04/2026 -
ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board
08/04/2026 -
Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis
08/04/2026 -
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
08/04/2026 -
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
08/04/2026 -
AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs
08/04/2026 -
Zelluna ASA – Disclosure of voting rights of Annual General Meeting
08/04/2026 -
Clariane has launched a proposed offering of €500 million of senior notes to refinance part of its existing indebtedness
08/04/2026 -
Clariane annonce l’offre de 500 millions d’euros d’obligations senior en vue de refinancer une partie de son endettement existant
08/04/2026 -
Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby
08/04/2026 -
Novonesis expands global footprint with acquisition of production facility in Southeast Asia
08/04/2026 -
DERMAdoctor Announces Initiative to Broaden Public Access to Dermatologist-Developed Clinical Skincare
08/04/2026 -
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy
08/04/2026 -
Fortrea dévoile Fortrea Intelligent Technology™ : une technologie destinée à permettre aux investigateurs et aux centres d’essais cliniques de mener des essais plus intelligents et mieux intégrés
08/04/2026 -
Leanzene Claims Evaluated: The Leading Keto BHB + ACV Weight Loss Gummy Brand on the Market
08/04/2026
Pages